Litigation Details for Ferring Pharmaceuticals Inc. v. Novel Laboratories, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Ferring Pharmaceuticals Inc. v. Novel Laboratories, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-07-05 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 8,450,338; 8,481,083 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Ferring Pharmaceuticals Inc. v. Novel Laboratories, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Ferring Pharmaceuticals Inc. v. Novel Laboratories, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-07-05 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083; US… 5 July 2017 1:17-cv-00894-RGA Patent - Abbreviated New Drug Application(ANDA) | External link to document | |
| 2018-04-02 | 59 | 2 Patents: 8,450,338 (“the ‘338 patent”), 8,481,083 (“the ‘083 patent”) and 9,669,110 …for infringement of the ‘338 patent, the ‘083 patent, and the ‘110 patent.8 Counts I and II assert respective…the ‘338 patent and the ‘083 patent, and Count III asserts infringement of the ‘110 patent.9 …21 C.F.R. § 314.53, the ‘338 patent and the ‘083 patent are listed in the FDA’s Approved Drug Products…parties also agree that the ‘110 patent is not an Orange Book patent for Prepopik®.5 C. Background | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
